WASHINGTON, Oct. 19, 2024 /PRNewswire/ -- The following statement is being issued regarding the Valeant Pharmaceuticals Fair Fund. UNITED STATES SECURITIES AND EXCHANGE COMMISSION In the Matter of Valeant Pharmaceuticals International, Inc. n/k/a Bausch Health Companies Inc.; J. Michael...
Investors in Common Stock and Certain Debt Securities Offered by Valeant Pharmaceuticals International, Inc. May be Entitled to Payment from an SEC Fair Fund
Seaking AlphaSeeking Alpha / Seaking Alpha 3 hours ago 1 Views
Comments